Women receiving transcatheter aortic valve implantation face higher periprocedural complication risks but better long-term survival than men.

PARIS, France—There is more than a twofold greater risk of death, and a significantly increased risk of major adverse cardiac events, over nearly 2 years of follow-up when patients with a bicuspid ...

Data on valve durability with transcatheter aortic valve replacement are reassuring at 7 years, with implications for ...

Transcatheter aortic valve implantation (TAVI) was superior to surgical aortic valve replacement for reducing death, stroke or rehospitalization in women with severe aortic stenosis, according to late ...

CHICAGO -- Dapagliflozin (Farxiga) lowered mortality and heart failure worsening in high-risk older adults getting transcatheter aortic valve implantation (TAVI), the DapaTAVI trial showed. In a ...

Thubrikar Aortic Valve, Inc. today announced successful results in the first two patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV™) using the new Precision 2™ Delivery ...

The findings should lead to changes in practice, David Cohen says, but as seen in the setting of PCI, “old habits die hard.” ...

The Ross procedure for aortic valve replacement, which involves a pulmonary valve autograft, achieved low rates of ...

Thubrikar Aortic Valve, Inc. today announced its partnership with MAC’s MEDICAL Group, a distributor of cardiovascular ...

Mizoram achieved a major milestone in advanced cardiac care after doctors at a private hospital here successfully carried out the state''s first Transcatheter Aortic Valve Implantation (TAVI), a ...

COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter ...